目的 探讨T2DM患者血糖控制情况及不同抗糖尿病治疗方案对HbA1c达标的影响.方法 横断面调查2008～2009年300例T2DM患者的HbA1c达标情况及其与抗糖尿病治疗方案的关系.结果 (1)T2DM患者HbA1c＜6.5％和7.0％达标率分别为38.3％和51.7％；(2)不同治疗方案组中,胰岛素联合口服药物组HbA1c最高(P＜0.05)；(3)口服药物组中,3种及以上药物组HbA1c最高(P＜0.05).结论 低胰岛素使用率是T2DM患者血糖控制不良因素之一,启动胰岛素治疗有望改善血糖控制状态.%Objective To investigate the status of blood glucose control in type 2 diabetic patients and the influence of different treatments on their target level of HbA1 c. Methods In this cross section investigation, the HbA1c and personal anti-diabetic regimens in 300 type 2 diabetic patients from 2008 to 2009 were recorded and the relationship between the target level of HbA1c and different treatments was analyzed. Results (1) Of the 300 patients, the patients with HbA1C <6. 5% & <7% was 38. 3% &-51. 7% respectively. (2) Of the groups with different treatments, the HbA1c was the highest in the group treated by insulin combined with oral anti-diabetic drugs (P<0. 05). (3) Of the oral anti-diabetic drug groups, the HbA1c was the highest in the group treated with 3 and more drugs (P<0. 05). Conclusion The conservative anti-diabetic regimens is an important factor for the poor blood glucose control in type 2 diabetic patients. Application of insulin early is helpful in improving the blood glucose control.
展开▼
